Anti-Human CD40 [G28.5] In Vivo Antibody - Low Endotoxin

(No reviews yet) Write a Review
SKU:
IVMB0013
Product Type:
In Vivo Monoclonal Antibody
Clone:
G28.5
Protein:
CD40
Isotype:
Mouse IgG1 kappa
Reactivity:
Human
Endotoxin Level:
Low Endotoxin
Host Species:
Mouse
Applications:
FA
FC
Frequently bought together:

Description

system_update_altTechnical Datasheet
Product Name:Anti-Human CD40 [G28.5] In Vivo Antibody - Low Endotoxin
Product Code:IVMB0013
Size:1mg, 5mg, 25mg, 50mg, 100mg
Clone:G28.5
Protein:CD40
Product Type:Monoclonal Antibody
Isotype:Mouse IgG1 κ
Reactivity:Human
Applications:FA, FC
Formulation:This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
Endotoxin Level:< 1.0 EU/mg as determined by the LAL method
Purity:≥95% monomer by analytical SEC
>95% by SDS Page
Preparation:Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling:Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Applications:FA, FC
Recommended Usage:FC
The suggested concentration for this G28.5 antibody for staining cells in flow cytometry is ≤ 1.0 µg per 106 in a volume of 100 µl or 100µl of whole blood. Titration of the reagent is recommended for optimal performance for each application.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Reactivity:Human
Host Species:Mouse
Specificity:Clone G28.5 recognizes an epitope on human CD40
Antigen Distribution:CD40 is widely expressed on antigen-presenting cells such as dendritic cells, B cells, macrophages, and monocytes, in addition to non-immune endothelial cells, basal epithelial cells, and a variety of tumors.
Concentration:≥ 2.0 mg/ml
Endotoxin Level:< 1.0 EU/mg as determined by the LAL method
Purity:≥95% monomer by analytical SEC
>95% by SDS Page
Formulation:This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
Preparation:Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling:Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.

CD40 is a 48 kD type I transmembrane glycoprotein that is a member of the TNFR superfamily. CD40, in association with its ligand CD154 (CD40L) - a 39 kD protein, acts as a costimulatory molecule for the activation of B cells, dendritic cells, monocytes, and other antigen presenting cells. CD40 is involved in Ig isotype switching and dendritic cell maturation, as well as the activation, differentiation and proliferation of B cells. CD40 interacts with TNFR2 and is involved in the regulation of signal transduction. CD40 is a potential target for cancer immunotherapy. Blocking the interaction of CD40 with its ligand (CD154) is the sought-after therapeutic objective for preventing and/or improving both autoimmune diseases and transplant rejection. Studies have shown that monoclonal antibodies that block CD154 in human clinical trials resulted in unanticipated vascular complications. Hence, an interest in the therapeutic potential for antagonist mAbs specific for human CD40 is emerging. Antibodies of particular therapeutic interest are those that do not inhibit CD40 signaling via physical competition with CD154. Additionally, the interaction of CD40 and its ligand (CD154) is found to be essential for amyloid-beta-induced microglial activation, thus plays a significant part in Alzheimer disease pathogenesis.

Technical Datasheet:View
Protein:CD40
Ligand/Receptor:CD154 (CD40L)
Research Area:Cell Biology, Costimulatory Molecules, Immunology, Neuroscience, Neuroscience Cell Markers
Product Thumbnail
Mouse IgG1 Isotype Control [HKSP]
Clone HKSP
Isotype Mouse IgG1
Endotoxin Level Low Endotoxin
Learn More
Product Thumbnail
Mouse IgG1 Isotype Control [HKSP84]
Clone HKSP84
Isotype Mouse IgG1
Endotoxin Level Low Endotoxin
Learn More

Meet the team!


Shane Costigan

Shane Costigan

Territory Manager & Team Lead

Abdul Khadim

Abdul Khadim

Sales Executive

0 Reviews

View AllClose

Related Products